According to Qiagen 's latest financial reports and stock price the company's current Operating Margin is 6.12%. At the end of 2024 the company had an Operating Margin of 6.12%.
Year | Operating Margin | Change |
---|---|---|
2024 | 6.12% | -72% |
2023 | 21.87% | -8.63% |
2022 | 23.94% | -13.88% |
2021 | 27.79% | 18.29% |
2020 | 23.50% | -561.15% |
2019 | -5.10% | -133.9% |
2018 | 15.03% | 86.29% |
2017 | 8.07% | 89.7% |
2016 | 4.25% | -60.03% |
2015 | 10.64% | 19.85% |
2014 | 8.88% | 209.58% |
2013 | 2.87% | -75.22% |
2012 | 11.57% | 40.68% |
2011 | 8.23% | -48.34% |
2010 | 15.92% | -6.71% |
2009 | 17.07% | 27.75% |
2008 | 13.36% | 14.62% |
2007 | 11.65% | -48.82% |
2006 | 22.77% | -6.72% |
2005 | 24.41% | 27.84% |
2004 | 19.10% | -0.22% |
2003 | 19.14% | 47.05% |
2002 | 13.02% | -39.04% |
2001 | 21.35% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() Thermo Fisher Scientific TMO | 16.47% | 169.12% | ๐บ๐ธ USA |
![]() Hologic HOLX | 21.46% | 250.65% | ๐บ๐ธ USA |
![]() Becton Dickinson BDX | 8.06% | 31.70% | ๐บ๐ธ USA |
![]() General Electric GE | 19.68% | 221.57% | ๐บ๐ธ USA |
![]() Bio-Techne TECH | 16.02% | 161.76% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.